万泰生物,603392,收入构成,报告日期,2020-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
疫苗分部,8096,553,7543,93.17%,11.36%
仪器分部,8795,7033,1762,20.03%,2.65%
试剂分部,62576,14384,48191,77.01%,72.57%
其他(补充),12011,2783,9229,76.83%,13.9%
分部间抵销,-7106,-6787,-319,4.49%,-0.48%


